^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    KD-025 CAR T-cells

    i
    Other names: KD-025 CAR T-cells, NKG2D-based CAR T-cells
    Associations
    News
    Trials
    Company:
    KAEDI
    Drug class:
    NKG2D-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials